AN ASSESSMENT OF QUALITY OF LIFE IN UTHIRAVATHA SURONITHAM(RHEUMATOID ARTHRITIS)PATIENTS REPORTING AT AYOTHIDOSS PANDITHAR HOSPITAL NATIONAL INSTITUTE OF SIDDHA A CROSS SECTIONAL STUDY
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- The outcome of this study will provide validate measure of quality of life and provide a tool for improving the evaluation of siddha medications for Uthiravatha Suronitham
研究概览
简要总结
Rheumatoid arthritis is the most commonpersistent inflammatory arthritis. The symptoms are pain, joint swelling andstiffness affecting the small joints of the hand, feet, and wrists. Large jointinvolvement, systemic symptoms and extra articular features may also occur. OBJECTIVE: To estimate the quality of life (QOL) inUthiravatha suronitham patients reporting at OPD of Ayothidoss Panditharhospital, NIS through Rheumatoid Arthritis Flare Questionnaire (RA-FQ) and toassess the predisposing factors of Uthiravatha suronitham with respect age,gender, chronicity of illness, personal history, occupational history, familyhistory, stress etc. MATERIALS ANDMETHODS: This is a Hospital based crosssectional study, included 100 Uthiravatha suronitham patients reported OPDof ayothidoss pandithar hospital were enrolled based on inclusion and exclusion criteria. After obtaininginformed consent form, data were collected by using Rheumatoid Arthritis Flare Questionnaire(RA-FQ) and Beck’s Depression Inventory form to estimate the quality of life. RESULTS : In 100 Uthiravatha suronithampatients, over all score is 42.9 in RA-FQ (Maximum 50) questionnaire. In beck’sdepression Inventory showed that 38%patients had Moderate depression and 33% patients had Severe depression. CONCLUSION: Rheumatoid arthritissignificantly affects the quality of life of patients both physically andmentally.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 30.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •Age 30 TO 65 Years Male Female and Transgender K/C/O Uthiravatha suronitham(Rheumatoid Arthritis)patients with sero negative sero positive RA Lab investigations patients who are willing to give informed consent.
排除标准
- •Age below 30 and above 65 years Patients with normal CRP Anti CCP test results Patient who are not willing to give consent form Patients defects (Osteoarthritis Psoriatic arthritis Gout arthritis).
结局指标
主要结局
The outcome of this study will provide validate measure of quality of life and provide a tool for improving the evaluation of siddha medications for Uthiravatha Suronitham
时间窗: 6months
次要结局
未报告次要终点
